Skip to main content
72°
Sunny
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Albireo Pharma Inc
(NQ:
ALBO
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EST, Mar 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Albireo Pharma Inc
< Previous
1
2
3
4
Next >
Analyst Ratings for Albireo Pharma
February 15, 2023
Via
Benzinga
ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO
January 24, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 20, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
Cowen & Co. Downgrades Albireo Pharma: Here's What You Need To Know
January 11, 2023
Via
Benzinga
Expert Ratings for Albireo Pharma
January 11, 2023
Via
Benzinga
Looking Into Albireo Pharma's Return On Capital Employed
December 05, 2022
Via
Benzinga
What 5 Analyst Ratings Have To Say About Albireo Pharma
October 12, 2022
Analysts have provided the following ratings for Albireo Pharma (NASDAQ:ALBO) within the last quarter:
Via
Benzinga
Why These Two Biotech Stocks Blasted Higher This Week
January 13, 2023
There's nothing like a big-premium buyout to send a company's share price to the moon.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 11, 2023
January 11, 2023
Via
Benzinga
ALBIREO PHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Albireo Pharma, Inc. - ALBO
January 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Paya Holdings Inc. (Nasdaq – PAYA), CinCor Pharma, Inc. (Nasdaq – CINC), Albireo (Nasdaq – ALBO), Duck Creek Technologies (Nasdaq - DCT)
January 10, 2023
From
Brodsky & Smith LLC
Via
GlobeNewswire
S&P 500 Gains 0.6%; Albireo Pharma Shares Spike Higher
January 09, 2023
U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023
January 10, 2023
Via
Benzinga
Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
January 09, 2023
Via
Benzinga
Nasdaq Surges Over 200 Points; Crude Oil Rises 2%
January 09, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 200 points on Monday.
Via
Benzinga
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday
January 09, 2023
The market is moving higher, and these small companies are helping.
Via
The Motley Fool
Tesla, Zillow, Albireo Pharma And Some Other Big Stocks Moving Higher On Monday
January 09, 2023
U.S. stocks traded higher, with the Dow Jones gaining more than 150 points on Monday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
US Stocks Open Higher; Dow Rises 150 Points
January 09, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 150 points on Monday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
January 09, 2023
Via
Benzinga
ALBO Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Albireo Pharma, Inc. Is Fair to Shareholders
January 09, 2023
From
Halper Sadeh LLC
Via
Business Wire
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 09, 2023
Via
Benzinga
Why CinCor Pharma Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket
January 09, 2023
Gainers CinCor Pharma, Inc. (NASDAQ: CINC) rose 140.2% to $28.30 in pre-market trading after AstraZeneca announced plans to buy the company for up to $1.8 billion.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
January 09, 2023
We're starting off the week with a look at the biggest pre-market stock movers traders need to know about on Monday morning!
Via
InvestorPlace
France-Based Ipsen Acquires Albireo Pharma Enriching Its Rare Disease Portfolio, Pipeline
January 09, 2023
Via
Benzinga
Have A Look At William Blair's Top Biotech Picks For 2023
December 25, 2022
William Blair & Company's report outlined some key themes and significant trends to monitor while entering 2023, providing its top stock ideas for the upcoming 12-month period.
Via
Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
November 09, 2022
Gainers
Via
Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
November 10, 2022
Gainers
Via
Benzinga
Analysts Expect Mirum Pharma's Liver Disease Candidate Might Exceed Rival Product's Penetration
October 25, 2022
Via
Benzinga
Albemarle To Rally Around 8%? Here Are 5 Other Price Target Changes For Thursday
October 13, 2022
Berenberg raised Albemarle Corporation (NYSE: ALB) price target from $260 to $270. Berenberg analyst Andres Castanos Mollor downgraded the stock from Buy to Hold. Albemarle shares fell 7.9% to close at...
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.